Showing results (3511-3520 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|February 28, 2018
Use of Targeted Therapeutics in Epithelial Ovarian Cancer: A Review of Current Literature and Future DirectionsMonica Hagan Vetter, John L HaysClinical Therapeutics|March 10, 2018
Impact of the Adalimumab Patient Support Program's Care Coach Calls on Persistence and Adherence in Canada: An Observational Retrospective Cohort StudyJohn K Marshall, Louis Bessette, Carter Thorne, et al.Clinical Therapeutics|December 5, 2017
Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover StudyCrista Johnson-Agbakwu, Louise Brown, James Yuan, et al.Clinical Therapeutics|December 25, 2017
Role of Physical Activity and Exercise in Alleviating Cognitive Impairment in People With EpilepsyJane B Allendorfer, Ricardo M AridaClinical Therapeutics|October 9, 2017
Enrollment of Neonates in More Than One Clinical TrialJonathan M Davis, Gerri R Baer, Ronald Portman, et al.Clinical Therapeutics|November 7, 2017
Canagliflozin in Conjunction With Sulfonylurea Maintains Glycemic Control and Weight Loss Over 52 Weeks: A Randomized, Controlled Trial in Patients With Type 2 Diabetes MellitusJean-François Yale, John Xie, Stephen E Sherman, et al.Clinical Therapeutics|April 27, 2016
Pharmacodynamic and Pharmacokinetic Equivalences of Epoetin Hospira and Epogen(®) After Multiple Subcutaneous Doses to Healthy Male SubjectsDennis Stalker, Atulkumar Ramaiya, Seema Kumbhat, et al.Clinical Therapeutics|October 10, 2017
Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting DatabasesLaura Park-Wyllie, Judy van Stralen, Genaro Castillon, et al.Clinical Therapeutics|October 26, 2006
Solifenacin succinate for the treatment of symptoms of overactive bladderMaria Maniscalco, Devada Singh-Franco, William R Wolowich, et al.Clinical Therapeutics|October 26, 2006
Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical studySheng-Hwu Hsieh, Jen-Der Lin, Hung-Yu Cheng, et al.Pageof 680